NMSU branding

New Mexico State University

New Mexico State University

News Center




Businessman Bradley Gordon to be honored at NMSU commencement

New Mexico State University will honor businessman and NMSU alum Bradley Gordon with an honorary degree during the fall 2010 commencement ceremony at 10 a.m. Saturday, Dec. 11, at the Pan American Center. Tickets are not required. The Pan American Center will open an hour before the ceremony.



New Mexico State University will honor businessman and NMSU alum Bradley Gordon with an honorary degree during the fall 2010 commencement ceremony at 10 a.m. Saturday, Dec. 11, at the Pan American Center. (Submitted photo)

Gordon will be honored for his generous support of the College of Business, for his leadership in the national and international business community and for his overall commitment to New Mexico State University - the place he credits for giving him a second chance.

Gordon earned a degree in marketing from NMSU in 1978, graduating near the top of his business school class. Gordon said he was helped by NMSU's smaller, more intimate classes, where he got to know his instructors and where they got to know him on a personal level.

To show his thanks, Gordon later established the Robin Peterson Chair in marketing. During the signing, he said that a person is born twice in their lives; the first when they are given life and the second when they find themselves. He noted that he was born at NMSU, where he excelled after several tries at other institutions, got the chance to start again, made close friends, learned to take chances, and dedicated himself seriously to a course of study.

Gordon went on to earn an MBA at the University of Southern California and later worked in venture capital. He then turned to launching several companies with other entrepreneurs. Since 1981 Gordon has been involved in the startup of 11 companies, mostly in the biotech field. He is now a retired corporate executive, serving most recently as vice president of finance and corporate planning of the Celgene Corporation, a New Jersey-based biopharmaceutical company.